Over the past decade, Swixx has grown rapidly, establishing itself as one of the largest, most professional, and most reliable partners for international healthcare companies across Central and Eastern Europe, Russia/Eurasia, and Greece.

The company continues to expand. In September 2023, Swixx broadened its footprint by entering new markets in the Middle East, and in May 2024, it established a presence in Latin America through a strategic merger and acquisition with Laboratorios Biopas SA. Leveraging Biopas’s extensive coverage across Latin America, Swixx now offers comprehensive solutions throughout Central and Eastern Europe, CIS/Eurasia, the MENA region, and Latin America.

Swixx believes that everyone deserves access to the latest evidence-based medical innovations. The company is proud to be the partner of choice for leading global healthcare companies in bringing their products to patients.